Morbidity of acute pancreatitis: The effect of aprotinin and glucagon

Abstract

In a double-blind, randomised trial, neither aprotinin nor glucagon given in relatively high doses for five days influenced the rate of recovery or incidence of complications in 257 patients with acute pancreatitis.